Your browser doesn't support javascript.
loading
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail.
Dong, Jinhui; Zost, Seth J; Greaney, Allison J; Starr, Tyler N; Dingens, Adam S; Chen, Elaine C; Chen, Rita E; Case, James Brett; Sutton, Rachel E; Gilchuk, Pavlo; Rodriguez, Jessica; Armstrong, Erica; Gainza, Christopher; Nargi, Rachel S; Binshtein, Elad; Xie, Xuping; Zhang, Xianwen; Shi, Pei-Yong; Logue, James; Weston, Stuart; McGrath, Marisa E; Frieman, Matthew B; Brady, Tyler; Tuffy, Kevin M; Bright, Helen; Loo, Yueh-Ming; McTamney, Patrick M; Esser, Mark T; Carnahan, Robert H; Diamond, Michael S; Bloom, Jesse D; Crowe, James E.
Afiliação
  • Dong J; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Zost SJ; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Greaney AJ; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Starr TN; Department of Genome Sciences & Medical Scientist Training Program, University of Washington, Seattle, WA, USA.
  • Dingens AS; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Chen EC; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Chen RE; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Case JB; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Sutton RE; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Gilchuk P; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Rodriguez J; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Armstrong E; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Gainza C; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Nargi RS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Binshtein E; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Xie X; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Zhang X; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Shi PY; Department of Biochemistry & Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Logue J; Department of Biochemistry & Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Weston S; Department of Biochemistry & Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • McGrath ME; Department of Microbiology and Immunology, The University of Maryland, College Park, MD, USA.
  • Frieman MB; Department of Microbiology and Immunology, The University of Maryland, College Park, MD, USA.
  • Brady T; Department of Microbiology and Immunology, The University of Maryland, College Park, MD, USA.
  • Tuffy KM; Department of Microbiology and Immunology, The University of Maryland, College Park, MD, USA.
  • Bright H; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA.
  • Loo YM; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA.
  • McTamney PM; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA.
  • Esser MT; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA.
  • Carnahan RH; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA.
  • Diamond MS; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA.
  • Bloom JD; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Crowe JE; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Nat Microbiol ; 6(10): 1233-1244, 2021 10.
Article em En | MEDLINE | ID: mdl-34548634
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 Limite: Humans Idioma: En Revista: Nat Microbiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 Limite: Humans Idioma: En Revista: Nat Microbiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos